Israeli generic drug giant Teva to buy Cephalon
Monday, May 2, 2011 - 09:50
in Mathematics & Economics
Teva Pharmaceutical Industries, the world's largest generic drug maker, will buy US biopharma firm Cephalon in a $6.8 billion deal, the companies said in a joint statement Monday.